Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Electrotherapy Companies

Electrotherapy companies specialize in the development and production of medical devices and equipment that use electrical impulses for therapeutic purposes. Electrotherapy is commonly used in physical therapy, rehabilitation, and pain management to stimulate nerves, muscles, and tissues.

*Disclaimer: List of key companies in no particular orderLatest Electrotherapy Companies Update

August 2023: Longbio Pharma (Suzhou) has announced positive results from a Phase I clinical trial of LP-003, a novel long-acting anti-IgE antibody for the treatment of allergic rhinitis. In a randomized, double-blind study, the pharmacokinetics, pharmacodynamics (free IgE levels), and safety of LP-003 in healthy subjects were evaluated. The subjects were randomized into five groups and administered a single intravenous dose of 0, 1, 3, 6, and 10 mg/kg, respectively. Patients exhibited a non-linear PK characteristic with a T1/2 ranging from 46,3 days to 75,6 days, which is approximately 23 times that of omalizumab. LP-003 also exhibited high IgE binding affinity (>100 fold) without off-target binding and more potent FcRI and FcRII/CD23 inhibition than omalizumab.

August 2023: Inimmune, a biotechnology company based in the United States, has dosed the first patient in a randomised, placebo-controlled Phase I/Ib study of INI-2004 for the treatment of allergic rhinitis. The Toll-Like Receptor 4 (TLR4) agonist product candidate INI-2004 will undergo a single ascending dose study in the first phase of the trial. It will be conducted under the supervision of the Therapeutic Goods Administration Authority and the Human Research Ethics Committee in Australia. The US Food and Drug Administration has also approved Inimmune's investigational new drug application for Phase Ib of the study. This phase will be conducted in the United States and will consist of a multiple ascending dose study with three cohorts. Patients with seasonal allergic rhinitis will be randomly assigned to receive multiple intranasal doses of INI-2004 or placebo in a 3:1 ratio.

List of Electrotherapy Key companies in the market

Medtronic Inc (Ireland)

Alimed

Cogentix Medical

Jude Medical

Zynex Medical (US)

DJO Global Inc. (US)

Livanova Plc (UK)

Nervo Corp (US)

Neuromextrix Inc. (US)

Boston Scientific Corporation (US)

Electrotherapy Market Highlights:

Electrotherapy Market Size

Electrotherapy Market Trends

Electrotherapy Market Analysis

Electrotherapy Market Share

Electrotherapy Market Highlights:

Electrotherapy Market Trends

Electrotherapy Market Analysis

Electrotherapy Market Share

Electrotherapy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.